Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Study of carboplatin based combination chemotherapy for good prognosis metastatic malignant teratoma
ISRCTN ISRCTN69711558
DOI 10.1186/ISRCTN69711558
ClinicalTrials.gov identifier
EudraCT number
Public title Study of carboplatin based combination chemotherapy for good prognosis metastatic malignant teratoma
Scientific title
Acronym N/A
Serial number at source TE09
Study hypothesis To define equivalent activity and lower toxicity of combination chemotherapy containing carboplatin rather than cisplatin
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer
Participants - inclusion criteria Histologically confirmed non-seminomatous germ cell tumour of testis or combined seminoma/teratoma or seminoma with unequivocal raised serum alpha feto protein concentration
Participants - exclusion criteria Previous chemotherapy.
Anticipated start date 01/06/1989
Anticipated end date 31/12/1993
Status of trial Completed
Patient information material
Target number of participants 450
Interventions Arm 1 - 4 cycles BEP.
Arm 2 - 4 cycles CEB.
Primary outcome measure(s) Complete remission on chemotherapy or chemotherapy + surgery. Progression-free survival. Survival, toxicity.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (UK)
Trial website
Publications Results on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=abstractplus&list_uids=9164194
Contact name Mrs  Pat  Cook
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Email pat.cook@ctu.mrc.ac.uk
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 28/02/2001
Last edited 11/09/2007
Date ISRCTN assigned 28/02/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.